Author:
Guo Xiao-bin,Ma Wan-le,Liu Li-juan,Huang Yu-ling,Wang Jing,Huang Li-hua,Peng Xiang-dong,Yin Ji-ye,Li Jin-gao,Chen Shao-jun,Yang Guo-ping,Wang Hui,Guo Cheng-xian
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference42 articles.
1. Cao SM, Simons MJ, Qian CN . The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer 2011; 30: 114–9.
2. Kamran SC, Riaz N, Lee N . Nasopharyngeal carcinoma. Surg Oncol Clin North Am 2015; 24: 547–61.
3. Wang W, Feng M, Fan Z, Li J, Lang J . Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. BioMed Res Int 2014; 2014: 814948.
4. Qiu WZ, Huang PY, Shi JL, Xia HQ, Zhao C, Cao KJ . Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study. Chin J Cancer 2016; 35: 2.
5. Zhang S, Lin S, Hu L . Lobaplatin combined with docetaxel neoadjuvant chemotherapy followed by concurrent lobaplatin with intensity-modulated radiotherapy increases the survival of patients with high-risk lymph node positive nasopharyngeal carcinoma. J BUON 2016; 21: 161–7.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献